Daniel R.  Hart net worth and biography

Daniel Hart Biography and Net Worth

Daniel Hart has served as Chief Financial Officer since August 2018 and has over 20 years of finance and accounting experience.  Prior to joining Avid, Mr. Hart served as Chief Financial Officer of ENO Holdings, Inc., a family of companies focused on the residential real estate market with offerings spanning brokerage, franchisor, property management, and settlement services.  In this role, he helped improve the company’s organizational results with a focus on establishing repeatable financial and operating processes, cash forecasts, strategic planning, and financial transactions.  Prior to this role, Mr. Hart served as Senior Vice President, Chief Financial Officer and Assistant Secretary at SM&A, a $100 million private equity owned management consulting firm that was previously a Nasdaq-listed company.  During his ten years at SM&A, which included several financial leadership positions of increasing responsibility, he was responsible for overseeing financial stewardship and played a central role in various financial transactions and corporate acquisitions.

Mr. Hart also previously held positions with Biolase Technology, Inc., a Nasdaq-listed medical device manufacturer, FutureLink Corp. a Nasdaq-listed hosted application service provider, and Deloitte & Touche LLP.

Mr. Hart holds a Bachelor of Science degree in accounting from California Polytechnic State University, San Luis Obispo and is a Certified Public Accountant in the State of California (inactive).

What is Daniel R. Hart's net worth?

The estimated net worth of Daniel R. Hart is at least $720,255.96 as of April 30th, 2024. Mr. Hart owns 82,221 shares of Avid Bioservices stock worth more than $720,256 as of May 8th. This net worth evaluation does not reflect any other investments that Mr. Hart may own. Additionally, Mr. Hart receives a salary of $719,750.00 as CFO at Avid Bioservices. Learn More about Daniel R. Hart's net worth.

How old is Daniel R. Hart?

Mr. Hart is currently 51 years old. There are 4 older executives and no younger executives at Avid Bioservices. The oldest executive at Avid Bioservices is Mr. Mark R. Ziebell J.D., VP, General Counsel & Corporate Secretary, who is 60 years old. Learn More on Daniel R. Hart's age.

What is Daniel R. Hart's salary?

As the CFO of Avid Bioservices, Inc., Mr. Hart earns $719,750.00 per year. The highest earning executive at Avid Bioservices is Mr. Nicholas Stewart Green B.Sc., MBA, President, CEO & Director, who commands a salary of $1,350,000.00 per year. Learn More on Daniel R. Hart's salary.

How do I contact Daniel R. Hart?

The corporate mailing address for Mr. Hart and other Avid Bioservices executives is 2642 Michelle Drive Suite 200, TUSTIN CA, 92780. Avid Bioservices can also be reached via phone at (714) 508-6100 and via email at [email protected]. Learn More on Daniel R. Hart's contact information.

Has Daniel R. Hart been buying or selling shares of Avid Bioservices?

Within the last three months, Daniel R. Hart has sold $20,912.40 of Avid Bioservices stock. Most recently, Daniel R. Hart sold 2,826 shares of the business's stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $7.40, for a transaction totalling $20,912.40. Following the completion of the sale, the chief financial officer now directly owns 82,221 shares of the company's stock, valued at $608,435.40. Learn More on Daniel R. Hart's trading history.

Who are Avid Bioservices' active insiders?

Avid Bioservices' insider roster includes Mark Bamforth (Director), Nicholas Green (CEO), Richard Hancock (Director), Daniel Hart (CFO), and Mark Ziebell (General Counsel). Learn More on Avid Bioservices' active insiders.

Are insiders buying or selling shares of Avid Bioservices?

In the last twelve months, Avid Bioservices insiders bought shares 2 times. They purchased a total of 43,000 shares worth more than $325,380.00. In the last twelve months, insiders at the biopharmaceutical company sold shares 23 times. They sold a total of 114,291 shares worth more than $1,346,895.31. The most recent insider tranaction occured on April, 30th when General Counsel Mark R Ziebell sold 1,643 shares worth more than $12,158.20. Insiders at Avid Bioservices own 2.4% of the company. Learn More about insider trades at Avid Bioservices.

Information on this page was last updated on 4/30/2024.

Daniel R. Hart Insider Trading History at Avid Bioservices

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/30/2024Sell2,826$7.40$20,912.4082,221View SEC Filing Icon  
1/10/2024Sell2,408$6.17$14,857.3679,305View SEC Filing Icon  
10/10/2023Sell2,040$9.20$18,768.0075,081View SEC Filing Icon  
7/10/2023Sell1,269$13.77$17,474.1364,420View SEC Filing Icon  
6/29/2023Sell6,884$12.70$87,426.8061,141View SEC Filing Icon  
4/10/2023Sell1,280$19.80$25,344.0048,549View SEC Filing Icon  
4/5/2023Sell1,250$19.00$23,750.0046,207View SEC Filing Icon  
3/14/2023Sell5,000$19.00$95,000.0046,957View SEC Filing Icon  
1/10/2023Sell1,499$14.44$21,645.5649,957View SEC Filing Icon  
10/10/2022Sell1,262$17.90$22,589.8047,020View SEC Filing Icon  
7/11/2022Sell4,324$17.75$76,751.0044,661View SEC Filing Icon  
7/8/2022Sell4,150$17.53$72,749.5036,743View SEC Filing Icon  
4/11/2022Sell726$18.56$13,474.5628,770View SEC Filing Icon  
1/10/2022Sell877$21.58$18,925.66View SEC Filing Icon  
1/3/2022Sell500$29.07$14,535.00View SEC Filing Icon  
10/11/2021Sell760$22.37$17,001.20View SEC Filing Icon  
7/12/2021Sell5,409$25.61$138,524.49View SEC Filing Icon  
7/13/2020Sell2,056$6.88$14,145.2820,039View SEC Filing Icon  
See Full Table

Daniel R. Hart Buying and Selling Activity at Avid Bioservices

This chart shows Daniel R Hart's buying and selling at Avid Bioservices by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avid Bioservices Company Overview

Avid Bioservices logo
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Read More

Today's Range

Now: $8.38
Low: $8.30
High: $8.80

50 Day Range

MA: $7.05
Low: $6.09
High: $8.79

2 Week Range

Now: $8.38
Low: $4.07
High: $18.65

Volume

1,006,752 shs

Average Volume

1,271,805 shs

Market Capitalization

$531.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.55